SYNTHETISCHE PEPTIDAMIDE

European patent · EP2064228 · In force

Register entry

Publication number
EP2064228
Application number
EP07870877
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 12, 2007
Published
Jun 3, 2009
Granted
Aug 29, 2012
Protection ends at the latest
Nov 11, 2027
Next annual fee due
Nov 30, 2026
IPC classes
C07K 5/107 (2006.01)
C07K 7/02 (2006.01)
A61K 38/07 (2006.01)
A61K 38/08 (2006.01)
Priority
US 858109 P 10.11.2006
US 928550 P 10.05.2007
PCT application
PCT/US2007/023858 12.11.2007
PCT publication
WO2008/057608 15.05.2008
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

Difelikefalin

C02064228/01 · Medicine · Granted · Protection from Nov 12, 2027 to Nov 11, 2032

Authorisation 68653 (Swissmedic, Aug 16, 2022)

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 30, 2025

    Agent removed

    Representative
    Bovard AG, Optingenstrasse 16, 3013 Bern (removed)

    Published in Swissreg on 30.12.2025

  2. Dec 30, 2025

    Agent entered

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 30.12.2025

  3. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  4. Jun 24, 2025

    Transferred

    Owner
    Cara Therapeutics, Inc., 400 Atlantic Street, Suite 500, Stamford, CT 06901, USA → Vifor Fresenius Medical Care Renal Pharma Ltd., Rechenstrasse 37, 9014 St. Gallen
    Representative
    Bovard AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 24.06.2025

  5. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  6. Apr 18, 2024

    Address changed

    Owner
    Cara Therapeutics, Inc., 4 Stamford Plaza, 107 Elm Street, 9th floor, Stamford, CT 06902, USA → Cara Therapeutics, Inc., 400 Atlantic Street, Suite 500, Stamford, CT 06901, USA

    Published in Swissreg on 18.04.2024

  7. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  8. Dec 6, 2022

    Change

    Published in Swissreg on 06.12.2022

2 earlier entries
  1. Oct 17, 2022

    Address changed

    Owner
    Cara Therapeutics, Inc., 1 Parrott Drive, Shelton, CT 06484, USA → Cara Therapeutics, Inc., 4 Stamford Plaza, 107 Elm Street, 9th floor, Stamford, CT 06902, USA

    Published in Swissreg on 17.10.2022

  2. Aug 29, 2012

    Granted

    Published in Swissreg on 29.08.2012

Parties

Holder

Vifor Fresenius Medical Care Renal Pharma Ltd.

Rechenstrasse 37, 9014 St. Gallen

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventor

SCHTEINGART, Claudio D.

San Diego, CA 92122, US

MENZAGHI, Frederique

Rye, NY 10580, US

JIANG, Guangcheng

San Diego, CA 92130, US

ALEXANDER, Roberta Vezza

San Diego, CA 92130, US

SUEIRAS-DIAZ, Javier

La Jolla, CA 92037, US

SPENCER, Robert H.

New Hope, PA 18938, US

CHALMERS, Derek T.

Riverside, CT 06878, US

LUO, Zhiyong

New City, NY 10956, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.